文献速递乳房整形与再造显微修复重建

无阿片麻醉对DIEP皮瓣术后并发症的影响:回顾性队列研究

Impact of opioid-free anesthesia on complications after deep inferior epigastric perforator flap surgery: A retrospective cohort study.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2020-09-30

本研究回顾性分析204例DIEP皮瓣重建患者,比较无阿片麻醉联合目标导向液体治疗与阿片麻醉联合自由液体治疗的并发症差异。结果显示两组主要并发症无差异,但OFA组轻微并发症更少(17.9% vs 51.4%,P<0.001),且术后阿片用量更少、住院时间更短、PONV和疼痛更轻。

要点

  • OFA组轻微并发症发生率显著低于OA组(17.9% vs 51.4%,P<0.001)。
  • OFA与更少术后阿片用量、更短住院时间、更轻PONV和疼痛相关。
  • 无既往恶心史患者中,OA组PONV发生率高于OFA组(12.7% vs 43.6%,P<0.001)。

核心结论

  • OFA联合目标导向液体治疗未减少DIEP皮瓣主要并发症,但显著降低轻微并发症。
  • OFA与更少术后阿片消耗、更短住院时间、更轻PONV和疼痛相关。

研究设计与样本

  • 单中心回顾性队列研究,纳入2014年4月至2019年3月在AZ Sint Jan Brugge行DIEP皮瓣重建的204例患者。
  • 55例接受OFA(右美托咪定、利多卡因、氯胺酮,术前及术中不用阿片)联合目标导向液体治疗。
  • 149例接受OA(舒芬太尼和瑞芬太尼)联合自由液体治疗。
  • 主要结局为Clavien-Dindo分级并发症和住院时间,次要结局包括皮瓣失败、PONV、术后疼痛、阿片用量和皮瓣温度。

主要发现

  • 主要并发症两组无差异,OFA组轻微并发症更少(17.9% vs 51.4%,P<0.001)。
  • OA组3例发生皮瓣失败,6例发生皮瓣血栓(OA 5例,OFA 1例)。
  • 无既往恶心史患者中,OA组PONV发生率高于OFA组(12.7% vs 43.6%,P<0.001)。
  • 有既往恶心史患者更常需要术后阿片,恶心发生率为60.87%。

临床怎么用

  • DIEP皮瓣重建可考虑OFA联合目标导向液体治疗以减少轻微并发症和术后阿片需求。
  • 对有既往恶心史患者应关注术后阿片需求及恶心管理。

局限性

  • 回顾性队列设计可能存在选择偏倚和混杂。
  • OFA组与OA组同时存在液体治疗策略差异,无法区分麻醉方式与液体管理的独立效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This study measured the number of complications after deep inferior epigastric perforator (DIEP) flap reconstruction performed under opioid-free anesthesia (OFA) combined with goal-directed fluid therapy or opioid anesthesia with liberal fluid therapy (OA). This retrospective cohort study consisted of 204 patients who underwent DIEP flap reconstruction at AZSint Jan Brugge between April 2014 and March 2019. Primary outcomes were complications, according to the Clavien-Dindo classification and the length of hospital stay (LOS). The secondary outcomes were flap failure, postoperative nausea and vomiting (PONV), postoperative pain, postoperative opioid consumption, and postoperative skin flap temperature. OFA included a combination of dexmedetomidine, lidocaine, and ketamine without any opioid administered pre- or intraoperatively. OA included a combination of sufentanil and remifentanil. OFA patients received strict goal-directed fluid therapy, whereas OA patients received liberal fluids to maintain perfusion pressure. All patients except 7 (TIVA with remifentanil) received inhalation anesthesia combined with an infusion of propofol. Of the 204 patients, 55 received OFA and 149 received OA. There were no differences in major complications, but fewer minor complications in the OFA group (17.9% vs. 51.4% and P < 0.001). Flap failure occurred in three patients of the OA group. Six patients developed flap thrombosis (five OA patients and one OFA patient). OFA was associated with fewer postoperative opioids, shorter LOS, less PONV, and less pain. In patients without previous nausea, the PONV incidence was higher in the OA group than in the OFA group (12.7% vs. 43.6% and P < 0.001). Patients with previous nausea more frequently required postoperative opioids and had a nausea rate of 60.87%.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Mulier H, De Frene B, Benmeridja L, et al. Impact of opioid-free anesthesia on complications after deep inferior epigastric perforator flap surgery: A retrospective cohort study. J Plast Reconstr Aesthet Surg. 2020. PMID: 33268289. doi:10.1016/j.bjps.2020.09.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。